Natural killer cell activation by respiratory syncytial virus-specific antibodies is decreased in infants with severe respiratory infections and correlates with Fc-glycosylation
Authors:
- Elisabeth A. van ErpEEElisabeth A. van Erp
- Anke J. LakerveldALAnke J. Lakerveld
- Erik de GraafEGErik de Graaf
- Mads D. LarsenMLMads D. Larsen
- Rutger M. ScheppRSRutger M. Schepp
- Agnes L. Hipgrave EderveenAEAgnes L. Hipgrave Ederveen
- Inge M. L. AhoutIAInge M. L. Ahout
- Cornelis A. M. de HaanCHCornelis A. M. de Haan
- Manfred WuhrerMWManfred Wuhrer
- Willem LuytjesWLWillem Luytjes
- Gerben FerwerdaGFGerben Ferwerda
- Gestur VidarssonGestur Vidarsson
Preprint
Abstract
Background: Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections in infants and there is no vaccine available. In early life, the most important contributors to protection against infectious diseases are the innate immune system and maternal antibodies. However, the mechanisms by which antibodies can protect against RSV disease are incompletely understood, as both antibody levels and neutralization capacity correlate poorly with protection. We therefore asked whether antibody-mediated natural killer (NK) cell activation correlates with RSV disease. Methods: We performed an observational case-control study including infants hospitalized for RSV infection (n=43, cases), hernia surgery (n=16, controls), or RSV-negative viral respiratory tract infections (n=18, controls). First, we determined RSV antigen-specific antibody levels in infant plasma using a multiplex immunoassay. Subsequently, we measured the capacity of these antibodies to activate NK cells. Finally, we assessed Fc-glycosylation of the RSV-specific antibodies by mass spectrometry. Results: We found that RSV-specific maternal antibodies potently activate NK cells in vitro . While the concentrations of RSV-specific antibodies did not differ between cases and controls, antibodies from infants hospitalized for severe lower respiratory tract infections (RSV and/or other) induced significantly less NK cell interferon gamma production than those from uninfected controls. Furthermore, NK cell activation correlated with Fc-fucosylation of RSV-specific antibodies, but their glycosylation status did not significantly differ between cases and controls. Conclusions: Our results suggest that Fc-dependent antibody function and quality, exemplified by NK cell activation and glycosylation, contribute to protection against severe RSV disease and warrant further studies to evaluate the potential of harnessing these activities to develop an effective vaccine.Keywords
All Related Versions
- Published version: Clinical & Translational Immunology, 9 (2), e1112.
This publication has 62 references indexed in Scilit:
- Vaccine-Induced Anti-HA2 Antibodies Promote Virus Fusion and Enhance Influenza Virus Respiratory DiseaseScience Translational Medicine, 2013
- Affinity-Purified Respiratory Syncytial Virus Antibodies from Intravenous Immunoglobulin Exert Potent Antibody-Dependent Cellular CytotoxicityPLOS ONE, 2013
- Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activityJournal of Clinical Investigation, 2013
- Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene FamilyJournal of Virology, 2012
- Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy TrialNew England Journal of Medicine, 2012
- Natural Killer Cells Are Involved in Acute Lung Immune Injury Caused by Respiratory Syncytial Virus InfectionJournal of Virology, 2012
- Interleukin 18 Coexpression during Respiratory Syncytial Virus Infection Results in Enhanced Disease Mediated by Natural Killer CellsJournal of Virology, 2010
- Natural killer cells in infection and inflammation of the lungImmunology, 2009
- The Burden of Respiratory Syncytial Virus Infection in Young ChildrenNew England Journal of Medicine, 2009
- Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular ToxicityJournal of Biological Chemistry, 2002